Senti Biosciences (SNTI) Stock Statistics & Valuation Metrics

Senti Biosciences has a market cap or net worth of $78.77M. The enterprise value is $16.29M.

Senti Biosciences has 26,081,139 shares outstanding. The number of shares has decreased by -2.65% in one year.

Senti Biosciences’s return on equity (ROE) is -2.06 and return on invested capital (ROIC) is -68.32%.

The current PE Ratio of Senti Biosciences is -0.31. Senti Biosciences’s PEG ratio is >-0.01.

In the last 12 months, Senti Biosciences had revenue of 0.00 and earned -52.79M in profits. Earnings per share was -11.49.

In the last 12 months, operating cash flow was -43.77M and capital expenditures -11.00K, giving a free cash flow of -43.78M billion.

Senti Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Senti Biosciences upcoming earnings date is Aug 19, 2025, TBA Not Confirmed.

Senti Biosciences as a current ratio of 4.49, with Debt / Equity ratio of 29.15%

In the past 12 months, Senti Biosciences has paid 0.00 in taxes.

Senti Biosciences EV to EBITDA ratio is -0.03, with an EV/FCF ratio of -0.04.

Senti Biosciences has $33.80M in cash and marketable securities with $32.45M in debt, giving a net cash position of -$1.36M billion.

Gross margin is 8.54%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Senti Biosciences is $8.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy